EDGEMOND JAMES (CFO AND TREASURER) sold 34.6% of their position (10K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.73M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+10K
Price / share
$135.42
Trade value
$1.35M
% of position
Common Stock
Shares
−1.29K
Price / share
$569.46
Trade value
$734.04K
% of position
Common Stock
Shares
−2.06K
Price / share
$570.17
Trade value
$1.17M
% of position
Common Stock
Shares
−1.50K
Price / share
$571.42
Trade value
$854.85K
% of position
Common Stock
Shares
−1.36K
Price / share
$572.32
Trade value
$776.07K
% of position
Common Stock
Shares
−480.00
Price / share
$573.22
Trade value
$275.15K
% of position
Common Stock
Shares
−661.00
Price / share
$574.57
Trade value
$379.79K
% of position
Common Stock
Shares
−530.00
Price / share
$575.26
Trade value
$304.89K
% of position
Common Stock
Shares
−89.00
Price / share
$576.68
Trade value
$51.32K
% of position
Common Stock
Shares
−893.00
Price / share
$577.59
Trade value
$515.79K
% of position
Common Stock
Shares
−476.00
Price / share
$578.42
Trade value
$275.33K
% of position
Common Stock
Shares
−591.00
Price / share
$579.80
Trade value
$342.66K
% of position
Common Stock
Shares
−80.00
Price / share
$580.45
Trade value
$46.44K
% of position
Net shares
+0.00
Net value
-$4.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | M · Option Exercise | +10K | $135.42 | $1.35M | 53.0% | 18.88K | 28.88K |
| Common Stock Direct | 5/11/2026 | S · Sale | −1.29K | $569.46 | $734.04K | 4.5% | 28.88K | 27.59K |
| Common Stock Direct | 5/11/2026 | S · Sale | −2.06K | $570.17 | $1.17M | 7.5% | 27.59K | 25.53K |
| Common Stock Direct | 5/11/2026 | S · Sale | −1.50K | $571.42 | $854.85K | 5.9% | 25.53K | 24.03K |
| Common Stock Direct | 5/11/2026 | S · Sale | −1.36K | $572.32 | $776.07K | 5.6% | 24.03K | 22.68K |
| Common Stock Direct | 5/11/2026 | S · Sale | −480.00 | $573.22 | $275.15K | 2.1% | 22.68K | 22.20K |
| Common Stock Direct | 5/11/2026 | S · Sale | −661.00 | $574.57 | $379.79K | 3.0% | 22.20K | 21.54K |
| Common Stock Direct | 5/11/2026 | S · Sale | −530.00 | $575.26 | $304.89K | 2.5% | 21.54K | 21K |
| Common Stock Direct | 5/11/2026 | S · Sale | −89.00 | $576.68 | $51.32K | 0.4% | 21K | 20.92K |
| Common Stock Direct | 5/11/2026 | S · Sale | −893.00 | $577.59 | $515.79K | 4.3% | 20.92K | 20.02K |
| Common Stock Direct | 5/11/2026 | S · Sale | −476.00 | $578.42 | $275.33K | 2.4% | 20.02K | 19.55K |
| Common Stock Direct | 5/11/2026 | S · Sale | −591.00 | $579.80 | $342.66K | 3.0% | 19.55K | 18.96K |
| Common Stock Direct | 5/11/2026 | S · Sale | −80.00 | $580.45 | $46.44K | 0.4% | 18.96K | 18.88K |
| Total | +0.00 | -$4.38M | ||||||
Stock Option
Common Stock
10K shares
Shares
−10K
Strike price
135.42
Held after
12.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock10K shares | 5/11/2026 | M · Option Exercise | −10K | 135.42 | — | 12.50K |